vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Energy Services of America CORP (ESOA). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $114.1M, roughly 1.6× Energy Services of America CORP). On growth, Energy Services of America CORP posted the faster year-over-year revenue change (13.4% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $16.8M). Over the past eight quarters, Energy Services of America CORP's revenue compounded faster (26.7% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Superior Energy Services is an American oil services company that operates as a holding company for a portfolio of oilfield equipment rentals and well oil and gas services brands.
AVNS vs ESOA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $114.1M |
| Net Profit | $-1.3M | — |
| Gross Margin | 47.5% | 12.3% |
| Operating Margin | 1.4% | 4.3% |
| Net Margin | -0.7% | — |
| Revenue YoY | 0.7% | 13.4% |
| Net Profit YoY | 99.7% | — |
| EPS (diluted) | $-0.02 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $114.1M | ||
| Q3 25 | $177.8M | $130.1M | ||
| Q2 25 | $175.0M | $103.6M | ||
| Q1 25 | $167.5M | $76.7M | ||
| Q4 24 | $179.6M | $100.6M | ||
| Q3 24 | $170.4M | $104.7M | ||
| Q2 24 | $171.7M | $85.9M | ||
| Q1 24 | $166.1M | $71.1M |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-1.4M | — | ||
| Q2 25 | $-76.8M | — | ||
| Q1 25 | $6.6M | — | ||
| Q4 24 | $-397.3M | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $-900.0K | — |
| Q4 25 | 47.5% | 12.3% | ||
| Q3 25 | 48.4% | 12.6% | ||
| Q2 25 | 52.6% | 11.6% | ||
| Q1 25 | 53.6% | 0.1% | ||
| Q4 24 | 54.6% | 10.2% | ||
| Q3 24 | 54.5% | 16.8% | ||
| Q2 24 | 55.7% | 17.8% | ||
| Q1 24 | 57.1% | 8.8% |
| Q4 25 | 1.4% | 4.3% | ||
| Q3 25 | 0.1% | 5.8% | ||
| Q2 25 | -42.6% | 3.1% | ||
| Q1 25 | 6.1% | -10.6% | ||
| Q4 24 | -233.0% | 1.6% | ||
| Q3 24 | 7.0% | 8.4% | ||
| Q2 24 | 3.7% | 9.9% | ||
| Q1 24 | 2.4% | -1.5% |
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.8% | — | ||
| Q2 25 | -43.9% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | -221.2% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | -0.5% | — |
| Q4 25 | $-0.02 | $0.16 | ||
| Q3 25 | $-0.03 | $0.26 | ||
| Q2 25 | $-1.66 | $0.12 | ||
| Q1 25 | $0.14 | $-0.41 | ||
| Q4 24 | $-8.64 | $0.05 | ||
| Q3 24 | $0.09 | $0.40 | ||
| Q2 24 | $0.04 | $1.06 | ||
| Q1 24 | $-0.02 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $16.7M |
| Total DebtLower is stronger | $90.3M | $62.0M |
| Stockholders' EquityBook value | $778.2M | $60.6M |
| Total Assets | $1.1B | $201.0M |
| Debt / EquityLower = less leverage | 0.12× | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $16.7M | ||
| Q3 25 | $70.5M | $12.2M | ||
| Q2 25 | $90.3M | $15.3M | ||
| Q1 25 | $97.0M | $9.9M | ||
| Q4 24 | $107.7M | $20.3M | ||
| Q3 24 | $89.0M | $12.9M | ||
| Q2 24 | $92.2M | $14.5M | ||
| Q1 24 | $75.8M | $12.1M |
| Q4 25 | $90.3M | $62.0M | ||
| Q3 25 | $93.4M | $72.2M | ||
| Q2 25 | $95.7M | $59.1M | ||
| Q1 25 | $98.0M | $50.7M | ||
| Q4 24 | $125.3M | $59.6M | ||
| Q3 24 | $152.6M | $33.9M | ||
| Q2 24 | $164.9M | $31.9M | ||
| Q1 24 | $167.2M | $45.7M |
| Q4 25 | $778.2M | $60.6M | ||
| Q3 25 | $778.0M | $59.2M | ||
| Q2 25 | $776.3M | $54.4M | ||
| Q1 25 | $839.4M | $53.7M | ||
| Q4 24 | $828.5M | $61.0M | ||
| Q3 24 | $1.2B | $58.7M | ||
| Q2 24 | $1.2B | $52.0M | ||
| Q1 24 | $1.2B | $34.6M |
| Q4 25 | $1.1B | $201.0M | ||
| Q3 25 | $1.1B | $215.2M | ||
| Q2 25 | $1.0B | $189.1M | ||
| Q1 25 | $1.1B | $170.2M | ||
| Q4 24 | $1.2B | $192.1M | ||
| Q3 24 | $1.7B | $158.2M | ||
| Q2 24 | $1.7B | $148.8M | ||
| Q1 24 | $1.7B | $136.1M |
| Q4 25 | 0.12× | 1.02× | ||
| Q3 25 | 0.12× | 1.22× | ||
| Q2 25 | 0.12× | 1.09× | ||
| Q1 25 | 0.12× | 0.94× | ||
| Q4 24 | 0.15× | 0.98× | ||
| Q3 24 | 0.12× | 0.58× | ||
| Q2 24 | 0.13× | 0.61× | ||
| Q1 24 | 0.14× | 1.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $18.8M |
| Free Cash FlowOCF − Capex | $21.3M | $16.8M |
| FCF MarginFCF / Revenue | 11.8% | 14.7% |
| Capex IntensityCapex / Revenue | 3.8% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $3.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $18.8M | ||
| Q3 25 | $14.0M | $-9.3M | ||
| Q2 25 | $6.8M | $3.4M | ||
| Q1 25 | $25.7M | $1.1M | ||
| Q4 24 | $57.9M | $8.9M | ||
| Q3 24 | $23.0M | $-847.5K | ||
| Q2 24 | $27.8M | $19.3M | ||
| Q1 24 | $-8.0M | $-2.7M |
| Q4 25 | $21.3M | $16.8M | ||
| Q3 25 | $7.0M | $-12.0M | ||
| Q2 25 | $-4.2M | $-582.0K | ||
| Q1 25 | $19.0M | $-1.1M | ||
| Q4 24 | $53.1M | $6.0M | ||
| Q3 24 | $20.0M | $-2.9M | ||
| Q2 24 | $21.9M | $16.3M | ||
| Q1 24 | $-12.1M | $-4.9M |
| Q4 25 | 11.8% | 14.7% | ||
| Q3 25 | 3.9% | -9.3% | ||
| Q2 25 | -2.4% | -0.6% | ||
| Q1 25 | 11.3% | -1.4% | ||
| Q4 24 | 29.6% | 5.9% | ||
| Q3 24 | 11.7% | -2.8% | ||
| Q2 24 | 12.8% | 18.9% | ||
| Q1 24 | -7.3% | -6.9% |
| Q4 25 | 3.8% | 1.8% | ||
| Q3 25 | 3.9% | 2.1% | ||
| Q2 25 | 6.3% | 3.9% | ||
| Q1 25 | 4.0% | 2.9% | ||
| Q4 24 | 2.7% | 2.9% | ||
| Q3 24 | 1.8% | 2.0% | ||
| Q2 24 | 3.4% | 3.6% | ||
| Q1 24 | 2.5% | 3.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
ESOA
| Electricals Mechanical And General | $49.4M | 43% |
| Gas And Petroleum Transmission | $24.1M | 21% |
| Cost Plus And TM Contracts | $23.3M | 20% |
| Transferred At Point In Time | $17.9M | 16% |
